A new strategy of synthesizing hexagonal metastable β-Ag 2 WO 4 at room temperature based on aliovalent Eu 3+ doping induced orthorhombic-to-hexagonal phase transition using coprecipitation method is offered. Both α-Ag 2 WO 4 and β-Ag 2 WO 4 phase were characterized systematically using X-ray diffraction (XRD), Raman spectroscopy, Fourier transformed infrared spectroscopy (FTIR), and time-resolved photoluminescence (TRPL). Emission spectra at low temperature (77K) show two clear bands in the case of α-Ag 2 WO 4 and β-Ag 2 WO 4, which are designated as PL1 (low wavelength region) and PL2 (high wavelength region). PL1 (∼430–440 nm) is attributed to charge transfer transition within tungsten octahedra in α-Ag 2 WO 4 where as it is attributed to a similar transition within the tungsten tetrahedral in β-Ag 2 WO 4 . Temperature-dependent studies showed that origin of PL2 emission in α-Ag 2 WO 4 and β-Ag 2 WO 4 might be different. PL2 in the case of α-Ag 2 WO 4 is because of presence of F + center (singly ionized oxygen vacancy) within the band gap which is supported by density function theory measurement (DFT). Doping Eu 3+ in α-Ag 2 WO 4 diminishes PL2 emission. Lifetime measurement supports that, in the case of β-Ag 2 WO 4, both PL1 and PL2 might have common origin, i.e., charge transfer transition.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: